Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

48.16
Delayed Data
As of Oct 20
 +0.76 / +1.60%
Today’s Change
22.17
Today|||52-Week Range
49.50
+43.76%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close47.40
Today’s open47.83
Day’s range47.44 - 48.61
Volume123,020
Average volume (3 months)193,901
Market cap$919.4M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-72.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-45.13%
P/E ratioNM
Price/Sales5.80
Price/Book3.40

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.04+0.62%
TGTXTG Therapeutics Inc+1.10+14.67%
PTCTPTC Therapeutics Inc+0.12+0.68%
ADROAduro Biotech Inc-0.03-0.27%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 20, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$88.3M
Annual profit (last year)$21.7M
Net profit margin24.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
CFO, Principal Accounting Officer &
SVP-Finance
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts